Today in the News
SEE OTHER BRANDS

The latest news on global issues

Today in the News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Today in the News.

Press releases published on June 2, 2025

Crawford United Corporation Publishes Investor Presentation on Company Website

Crawford United Corporation Publishes Investor Presentation on Company Website

CLEVELAND, June 02, 2025 (GLOBE NEWSWIRE) -- Crawford United Corporation (OTC: CRAWA) announced today that contemporaneously with this press release it has posted investor presentation materials containing supplemental information for investors and other …

Calidi Biotherapeutics Presents systemic oncolytic platform with CD55-Enhanced expression and IL-15 Superagonist Payload at ASCO Annual Meeting

Calidi Biotherapeutics Presents systemic oncolytic platform with CD55-Enhanced expression and IL-15 Superagonist Payload at ASCO Annual Meeting

SAN DIEGO, June 02, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company pioneering the development of systemic oncolytic targeted immunotherapies with the ability to deliver genetic …

GRR! Rebrands to Heidelberg Materials

GRR! Rebrands to Heidelberg Materials

Irving, Texas, June 02, 2025 (GLOBE NEWSWIRE) -- Heidelberg Materials North America is pleased to announce that its recently acquired subsidiary, Giant Resource Recovery (GRR!), will rebrand to Heidelberg Materials Giant Resource Recovery (GRR) effective …

Applied Digital Announces 250MW AI Data Center Lease With CoreWeave in North Dakota

Applied Digital Announces 250MW AI Data Center Lease With CoreWeave in North Dakota

DALLAS, June 02, 2025 (GLOBE NEWSWIRE) -- Applied Digital Corporation (Nasdaq: APLD), a designer, builder and operator of next-generation digital infrastructure for HPC applications, has entered into two approximately 15-year lease agreements with …

Lightbridge Completes Final Experiment Design for Designated ATR Core Position

Lightbridge Completes Final Experiment Design for Designated ATR Core Position

RESTON, Va., June 02, 2025 (GLOBE NEWSWIRE) -- Lightbridge Corporation (Nasdaq: LTBR), a leader in advanced nuclear fuel technology, today announced the completion of the final design review for its upcoming irradiation experiment, marking a critical step …

Webus Signs up to $300 Million XRP Treasury Management Agreement with Top-Tier Manager Samara Alpha, Making a Major Step in Its XRP Treasury Strategy

Webus Signs up to $300 Million XRP Treasury Management Agreement with Top-Tier Manager Samara Alpha, Making a Major Step in Its XRP Treasury Strategy

Hangzhou, CHINA, June 02, 2025 (GLOBE NEWSWIRE) -- Webus International Limited (“Webus” or the “Company”) (NASDAQ: WETO), a leading provider of AI-driven mobility solutions specializing in premium, customizable chauffeur services worldwide, today announced …

TG Therapeutics to Participate in the Jefferies Global Healthcare Conference

TG Therapeutics to Participate in the Jefferies Global Healthcare Conference

NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced that Michael S. Weiss, the Company’s Chairman and Chief Executive Officer, will participate in the Jefferies Global Healthcare Conference, being held at the …

Aventis Energy Announces Appointment of Michael Mulberry to the Board of Directors

Aventis Energy Announces Appointment of Michael Mulberry to the Board of Directors

VANCOUVER, British Columbia, June 02, 2025 (GLOBE NEWSWIRE) -- Aventis Energy Inc. (“Aventis” or the “Company”) (CSE: AVE | FRA: C0O0 | OTC: VBAMF), is pleased to announce that Mr. Michael Mulberry has been appointed to the board of directors of the …

FDA Accepts TransCon® CNP NDA for Priority Review

FDA Accepts TransCon® CNP NDA for Priority Review

– Once-weekly TransCon CNP demonstrated significantly higher annualized growth velocity, the primary endpoint, compared to placebo – Multiple benefits beyond linear growth were observed compared to placebo, with a safety and tolerability profile similar to …

PDS Biotech Unveils Updated Positive Data From VERSATILE-002 Trial and Additional Trials Evaluating Versamune® HPV to Treat Head and Neck Cancers at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting

PDS Biotech Unveils Updated Positive Data From VERSATILE-002 Trial and Additional Trials Evaluating Versamune® HPV to Treat Head and Neck Cancers at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting

Median overall survival data in first-line recurrent/metastatic (1L r/m) HNSCC remains durable at 30.0 months with additional follow-up of ~4.5 months beyond the initial abstract HPV16-positive is the most rapidly increasing HNSCC in the US VERSATILE-003 …

CareCloud to Present on AI Innovation at Maxim Group’s 2025 Virtual Tech Conference on June 3, 2025

CareCloud to Present on AI Innovation at Maxim Group’s 2025 Virtual Tech Conference on June 3, 2025

Somerset, N.J., June 02, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDO) (“CareCloud” or the “Company”), a leader in AI-driven healthcare technology solutions for medical practices and health systems nationwide, announced today that its Co- …

Animal Nutrition Chemicals Market Size Worth USD 77.32 Billion by 2031, Rising Requirement for High Quality and Nutritious Animal Feed Fuels the Demand | The Insight Partners

Animal Nutrition Chemicals Market Size Worth USD 77.32 Billion by 2031, Rising Requirement for High Quality and Nutritious Animal Feed Fuels the Demand | The Insight Partners

US …

Frozen Food Market Size to expected to reach US$ 444.22 Billion by 2031, Rising Demand for Convenience Food Drives Growth | The Insight Partners

Frozen Food Market Size to expected to reach US$ 444.22 Billion by 2031, Rising Demand for Convenience Food Drives Growth | The Insight Partners

US …

Context Therapeutics Announces CTIM-76 Trial in Progress Poster Presentation at 2025 ASCO Meeting

Context Therapeutics Announces CTIM-76 Trial in Progress Poster Presentation at 2025 ASCO Meeting

Dosing cohort 3 of Phase 1 trial of CTIM-76, a Claudin 6 x CD3 T cell engager Expect to share initial data in the first half of 2026 PHILADELPHIA, June 02, 2025 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or “Company”) (Nasdaq: CNTX), a …

BridgeBio to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference 2025

BridgeBio to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference 2025

PALO ALTO, Calif., June 02, 2025 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, today announced that members of its management team will …

Amerigo Announces Board Appointment

Amerigo Announces Board Appointment

VANCOUVER, British Columbia, June 02, 2025 (GLOBE NEWSWIRE) -- Amerigo Resources Ltd. (TSX: ARG; ARREF:OTC) (“Amerigo” or the “Company”) is pleased to announce the appointment of Ignacio Cruz to the Company’s board of directors. Ignacio Cruz is a Civil …

Papa Johns Canada Introduces Cheddar Crust Pizza, A New Take on a Classic Favourite

Papa Johns Canada Introduces Cheddar Crust Pizza, A New Take on a Classic Favourite

EDMONTON, Alberta, June 02, 2025 (GLOBE NEWSWIRE) -- There’s a new reason to get excited about pizza night in Canada. Papa Johns is turning up the flavour with its latest menu addition: Cheddar Crust Pizza — a golden, cheesy twist on the classic crust fans …

Southern Realty Trust Expands Revolving Credit Facility to $100 Million with Addition of EverBank as Joint Lead Arranger

Southern Realty Trust Expands Revolving Credit Facility to $100 Million with Addition of EverBank as Joint Lead Arranger

WEST PALM BEACH, Fla., June 02, 2025 (GLOBE NEWSWIRE) -- Southern Realty Trust Inc. (“SRT” or the “Company”), a lender on the TCG Real Estate platform, today announced the expansion of its senior secured revolving credit facility (the “Credit Facility”) …

Prelude Therapeutics to Participate in Upcoming Healthcare Conferences

Prelude Therapeutics to Participate in Upcoming Healthcare Conferences

WILMINGTON, Del., June 02, 2025 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Prelude) (Nasdaq: PRLD), a clinical-stage precision oncology company, announced today that the Company will participate in two upcoming healthcare conferences in June. …

Repeat: EAT & BEYOND ANNOUNCES PROPOSED NAME CHANGE AND UPDATED INVESTMENT POLICY

Repeat: EAT & BEYOND ANNOUNCES PROPOSED NAME CHANGE AND UPDATED INVESTMENT POLICY

VANCOUVER, BC, June 02, 2025 (GLOBE NEWSWIRE) -- Eat …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service